U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Interferon alfa-2b, Recombinant for Injection
Status: Discontinuation
»Therapeutic Categories: Antiviral; Oncology

Expand all

Merck Sharp & Dohme Corp. (New 04/23/2021)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
INTRON A Powder for Injection (Interferon alfa-2b) 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4350-01) N/A
INTRON A Powder for Injection (Interferon alfa-2b) 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent ((NDC 0085-4351-01)) N/A
INTRON A Powder for Injection (Interferon alfa-2b) 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01) N/A
INTRON A Powder for Injection (Interferon alfa-2b), 10 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4350-01) N/A
INTRON A Powder for Injection (Interferon alfa-2b), 18 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 vial of INTRON A and 1 vial of INTRON A Diluent (NDC 0085-4351-01) N/A
INTRON A Powder for Injection (Interferon alfa-2b), 50 million IU per vial and Diluent for INTRON A (Sterile Water for Injection USP) 5 mL per vial; boxes containing 1 INTRON A vial and 1 vial of INTRON A Diluent (NDC 0085-4352-01) N/A
Back to Top